Industry Outlook
Sinusitis treatment drugs market accounted for a market value of US$ 2,006.9 Mn in 2017 and projected to grow at a CAGR of 3.2% during the forecast period from 2018 to 2026. Sinusitis is an inflammation of the paranasal sinuses caused due to allergy, autoimmune reactions or physical obstructions. According to American Academy of Allergy Asthma & Immunology (AAAAI), sinusitis is of two types acute and chronic where acute sinusitis symptoms lasts for less than four weeks while chronic sinusitis is diagnosed when symptoms last for more than 12 weeks. According to Sinuwave Technologies Corporation, sinusitis affects around 40% of the population in the United States and results around US$ 8.6 Bn in annual treatment expenditure every year. According to medical experts, acute sinusitis is usually of viral etiology and patients are treated with supportive therapies such as nasal irrigation. In case of chronic sinusitis, patients are on multiple regimes of antibiotics, local & systemic corticosteroid therapy, and other drugs. High prevalence of sinusitis and even higher incidence in the urban population are the key factors driving the global sinusitis drugs market. Shift in lifestyle, growing urbanization and industrialization, and similar such factors have led to increased air, water, and soil pollution worldwide. This, as a result, has led to increased exposure to infection-causing virus and bacteria thereby growing the risk of sinusitis. Additionally, evolution in the diagnosis of sinusitis from physical examination to the novel endoscopy and computed tomography imaging techniques have led to increased diagnosis rate of sinusitis. This, in turn, has augmented the potential patient pool and thereby increased the demand for sinusitis treatments.
Market Synopsis
Decongestant & mucolytic agents are the first choice of drug against non-microbial sinusitis that is highly prevalent
In year 2017, decongestant & mucolytic agents accounted for the largest market share and expected to maintain its dominance throughout the forecast period. The key factors responsible for market growth are first line of action for non-infectious sinusitis, upcoming novel technologies of drug delivery, and increasing patient-awareness has assisted the growth in disease diagnosis rate. During the forecast period from 2018 to 2016, antibiotics observed as fastest growing segment due to key market drivers such as developing diagnostics technologies. As per the latest research quote published by National Institute of Health (NIH), the incidence of acute sinusitis is 15 to 40 episodes in 1000 patients per year. Acute sinusitis is the second most common infectious disease encountered by general practitioners throughout the globe.
Increasing awareness in the population about the severity of sinusitis and rapid adoption of novel diagnostic techniques Asia Pacific is fastest growing region globally
North America dominated the sinusitis treatment drugs market due to key factors such as rising prevalence of sinusitis coupled with developed diagnostic technologies, and high disease awareness in patients & medical practitioners. In addition, upcoming novel drug delivery technologies expected to assist the market growth in the near future. During the forecast period from 2018 to 2026, Asia Pacific observed as the fastest growing region due to factors such as rising prevalence of sinusitis along with increasing awareness about the nasal & sinus disorders in patients, and developing healthcare infrastructure with skilled healthcare professionals. In addition, swift urbanization and industrialization in key countries such as China, India, and Indonesia, leading to air pollution in urban areas and increasing the risk of sinusitis. China and India alone house the largest share of the global population, therefore presenting a significant patient pool.
Historical & Forecast Period
2016 – Historical Year
2017 – Base Year
2018-2026 – Forecast Period
The sinusitis treatment market analyzed considering current market trends for base year 2017 and based on future trends CAGRs calculated for the forecast period from 2018 to 2026.
Report Scope by Segments
This report on sinusitis treatment market offers in-depth information related to market dynamics and global trends. The report provides comprehensive summary of the global sinusitis treatment market by segmenting the market based on treatment type, and geography. The objective of publishing this in-depth research report is to assist the industry stakeholders in carrying-out decisions and strategy implementation in the sinusitis treatment market.
Treatment Type Segment (2016–2026; US$ Mn)
Geography Segment (2016–2026; US$ Mn)
This report further describes the major qualitative assessment factors including key market trends, market drivers & restraints, to assist in better understanding of global sinusitis treatment market. Furthermore, the key players analyzed graphically based on their product offering, market strategies and business strength. The report also provides attractive investment proposition based on the extensive geographical research carried out based on PESTEL analysis. Key players profiled in the report include Pfizer, Inc., Janssen Pharmaceuticals, Abbott Laboratories, GlaxoSmithKline Plc, Sanofi SA, Novartis AG, and Teva Pharmaceutical Industries, Ltd. among others.
Key questions answered in this report
Chapter 1 Preface
1.1 Report Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.4 Assumptions
Chapter 2 Executive Summary
2.1 Global Sinusitis Treatment Drugs Market Portraiture
2.2 Global Sinusitis Treatment Drugs Market, by Treatment Type, 2017 (US$ Mn)
2.3 Global Sinusitis Treatment Drugs Market, by Geography, 2017 (US$ Mn)
Chapter 3 Global Sinusitis Treatment Drugs Market Analysis
3.1 Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 High Prevalence of Sinusitis
3.2.1.2 Rising Pollution Contributing to Increased Incidence of Sinusitis
3.2.2 Challenges
3.2.2.1 Overuse of Drugs and Excessive Self Medication
3.2.3 Market Opportunities
3.2.3.1 Big Opportunities for New Innovative Treatments
3.3 Attractive Investment Proposition, by Geography, 2017
3.4 Market Positioning: by Key Players in Sinusitis Treatment Drugs Market, 2016
Chapter 4 Global Sinusitis Treatment Drugs Market, by Treatment Type, 2018-2026 (US$ Mn)
4.1 Overview
4.2 Antibiotics
4.2.1 Cephalosporin Antibiotics
4.2.2 Penicillin/Beta Lactamase Inhibitors
4.2.3 Macrolide Antibiotics
4.2.4 Quinolone Antibiotics
4.3 NSAIDS
4.4 Decongestant & Mucolytic
4.4.1 Imidazoline Derivatives
4.4.2 Antihistamines
4.4.3 Corticosteroids
4.4.4 α₁-adrenergic receptor agonist
4.5 Nasal Irrigation Kits
4.6 Pipeline Analysis
4.6.1 Phase III
4.6.1.1 Omalizumab (F.Hoffman La-Roche AG)
4.6.2 Phase II and I (Tabular Format)
Chapter 5 Global Sinusitis Treatment Drugs Market, by Geography, 2016–2026 (US$ Mn)
5.1 Overview
5.2 North America
5.2.1 North America Sinusitis Treatment Drugs Market, by Treatment Type, 2016–2026 (US$ Mn)
5.2.2 North America Sinusitis Treatment Drugs Market, by Country, 2016–2026 (US$ Mn)
5.2.2.1 U.S.
5.2.2.2 Canada
5.3 Europe
5.3.1 Europe Sinusitis Treatment Drugs Market, by Treatment Type, 2016–2026 (US$ Mn)
5.3.2 Europe Sinusitis Treatment Drugs Market, by Region/Country, 2016–2026 (US$ Mn)
5.3.2.1 U.K.
5.3.2.2 Germany
5.3.2.3 Rest of Europe
5.4 Asia Pacific
5.4.1 Asia Pacific Sinusitis Treatment Drugs Market, by Treatment Type, 2016–2026 (US$ Mn)
5.4.2 Asia Pacific Sinusitis Treatment Drugs Market, by Region/Country, 2016–2026 (US$ Mn)
5.4.2.1 Japan
5.4.2.2 China
5.4.2.3 Rest of Asia Pacific
5.5 Latin America (LATAM)
5.5.1 Latin America Sinusitis Treatment Drugs Market, by Treatment Type, 2016–2026 (US$ Mn)
5.5.2 Latin America Sinusitis Treatment Drugs Market, by Region/Country, 2016–2026 (US$ Mn)
5.5.2.1 Brazil
5.5.2.2 Mexico
5.5.2.3 Rest of Latin America
5.6 Middle East & Africa (MEA)
5.6.1 Middle East & Africa Sinusitis Treatment Drugs Market, by Treatment Type, 2016–2026 (US$ Mn)
5.6.2 Middle East & Africa Sinusitis Treatment Drugs Market, by Region, 2016–2026 (US$ Mn)
5.6.2.1 GCC
5.6.2.2 Rest of Middle East & Africa
Chapter 6 Company Profiles
6.1 Pfizer, Inc.
6.2 Abbott Laboratories, Inc.
6.3 Janssen Pharmaceuticals, Inc.
6.4 GlaxoSmithkline, Plc.
6.5 Sanofi SA
6.6 Sandoz International GmbH (a subsidiary of Novartis International AG)
6.7 Bayer AG
6.8 Merck & Co., Inc.
6.9 Sun Pharmaceutical Industries Ltd.
6.10 Teva Pharmaceutical Industries Ltd.
FIG. 1 Research Methodology: Global Sinusitis Treatment Drugs Market
FIG. 2 Global Sinusitis Treatment Drugs Market, by Treatment Type, 2017 (US$ Mn)
FIG. 3 Global Sinusitis Treatment Drugs Market, by Geography, 2017 (US$ Mn)
FIG. 4 Classification of Adult Rhinosinusitis
FIG. 5 Attractive Investment Proposition: Global Sinusitis Treatment Drugs Market, by Geography, 2017
FIG. 6 Market Positioning of Key Players in Sinusitis Treatment Drugs Market, 2017
FIG. 7 Global Cephalosporin Antibiotics Market for Sinusitis Treatment, 2016-2026 (US$ Mn)
FIG. 8 Global Penicillin/Beta Lactamase Inhibitors Market for Sinusitis Treatment, 2016-2026 (US$ Mn)
FIG. 9 Global Macrolide Antibiotics Market for Sinusitis Treatment, 2016-2026 (US$ Mn)
FIG. 10 Global Quinolone Antibiotics Market for Sinusitis Treatment, 2016-2026 (US$ Mn)
FIG. 11 Global NSAIDS Market for Sinusitis Treatment, 2016-2026 (US$ Mn)
FIG. 12 Global Imidazoline Derivatives Market for Sinusitis Treatment, 2016-2026 (US$ Mn)
FIG. 13 Global Antihistamines Market for Sinusitis Treatment, 2016-2026 (US$ Mn)
FIG. 14 Global Corticosteroids Market for Sinusitis Treatment, 2016-2026 (US$ Mn)
FIG. 15 Global A₁-adrenergic Receptor Agonist Market for Sinusitis Treatment, 2016-2026 (US$ Mn)
FIG. 16 Global Nasal Irrigation Kits Market for Sinusitis Treatment, 2016-2026 (US$ Mn)
FIG. 17 U.S. Sinusitis Treatment Drugs Market, 2016–2026 (US$ Mn)
FIG. 18 Canada Sinusitis Treatment Drugs Market, 2016–2026 (US$ Mn)
FIG. 19 U.K. Sinusitis Treatment Drugs Market, 2016–2026 (US$ Mn)
FIG. 20 Germany Sinusitis Treatment Drugs Market, 2016–2026 (US$ Mn)
FIG. 21 Rest of Europe Sinusitis Treatment Drugs Market, 2016–2026 (US$ Mn)
FIG. 22 Japan Sinusitis Treatment Drugs Market, 2016–2026 (US$ Mn)
FIG. 23 China Sinusitis Treatment Drugs Market, 2016–2026 (US$ Mn)
FIG. 24 Rest of Asia Pacific Sinusitis Treatment Drugs Market, 2016–2026 (US$ Mn)
FIG. 25 Brazil Sinusitis Treatment Drugs Market, 2016–2026 (US$ Mn)
FIG. 26 Mexico Sinusitis Treatment Drugs Market, 2016–2026 (US$ Mn)
FIG. 27 Rest of Latin America Sinusitis Treatment Drugs Market, 2016–2026 (US$ Mn)
FIG. 28 GCC Sinusitis Treatment Drugs Market, 2016–2026 (US$ Mn)
FIG. 29 Rest of Middle East & Africa Sinusitis Treatment Drugs Market, 2016–2026 (US$ Mn)
TABLE 1 Global Sinusitis Treatment Drugs Market Portraiture
TABLE 2 Global Sinusitis Treatment Drugs Market, by Treatment Type, 2016–2026 (US$ Mn)
TABLE 3 Global Antibiotics Market for Sinusitis Treatment, 2016–2026 (US$ Mn)
TABLE 4 Global Decongestant & Mucolytic Market for Sinusitis Treatment, 2016–2026 (US$ Mn)
TABLE 5 Global Sinusitis Treatment Drugs Market, by Geography, 2016–2026 (US$ Mn)
TABLE 6 North America Sinusitis Treatment Drugs Market, by Treatment Type, 2016–2026 (US$ Mn)
TABLE 7 North America Sinusitis Treatment Drugs Market, by Country, 2016–2026 (US$ Mn)
TABLE 8 Europe Sinusitis Treatment Drugs Market, by Treatment Type, 2016–2026 (US$ Mn)
TABLE 9 Europe Sinusitis Treatment Drugs Market, by Region/Country, 2016–2026 (US$ Mn)
TABLE 10 Asia Pacific Sinusitis Treatment Drugs Market, by Treatment Type, 2016–2026 (US$ Mn)
TABLE 11 Asia Pacific Sinusitis Treatment Drugs Market, by Region/Country, 2016–2026 (US$ Mn)
TABLE 12 Latin America Sinusitis Treatment Drugs Market, by Treatment Type, 2016–2026 (US$ Mn)
TABLE 13 Latin America Sinusitis Treatment Drugs Market, by Region/Country, 2016–2026 (US$ Mn)
TABLE 14 Middle East & Africa Sinusitis Treatment Drugs Market, by Treatment Type, 2016–2026 (US$ Mn)
TABLE 15 Middle East & Africa Sinusitis Treatment Drugs Market, by Region, 2016–2026 (US$ Mn)
TABLE 16 Pfizer, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 17 Abbott Laboratories, Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 18 Jansenn Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 19 GlaxoSmithkline, Plc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 20 Sanofi SA: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 21 Sandoz International GmbH (a subsidiary of Novartis International AG): Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Bayer AG: Company Snapshot (Business Description; Financial Performance; Product Portfolio; Key Developments)
TABLE 23 Merck & Co., Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; Key Developments)
TABLE 24 Sun Pharmaceutical Industries Ltd.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; Key Developments)
TABLE 25 Teva Pharmaceutical Industries Ltd.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; Key Developments)
